Therapeutic
Therapeutic
In this section you will find information products, including market insight and company profiles, covering major therapeutic sectors, including CNS, Obesity, Oncology, Vaccines and Women\'s Health.Stay up-to-date with new products added to this category »
| Title | Publication Date | Price |
|---|---|---|
| Emerging Cancer Vaccines: Forecasts, Developments and Pipeline Analysis 4th Edition |
September 2010 | £2600 |
| Global Biometric Forecast to 2012 | September 2010 | £1040 |
| Vaccines: US industry forecasts for 2014 & 2019 | August 2010 | £3055 |
| Cytotoxic Therapies Market Forecast | August 2010 | £9885 |
| Oncology Adjuvants Technologies and Global Markets |
August 2010 | £3155 |
| Worldwide Personalized Medicine Market Enabling Equipment, Tools, Technologies, Players Drugs, Opportunities & Market Outlook |
August 2010 | £1495 |
| Commercial Insight: Cancer Targeted Therapies and Immunotherapies Top monoclonal antibody brands will resist competitive pressures through to 2019 |
August 2010 | £9885 |
| Intravenous (IV) Therapy and Vein Access Global Markets |
August 2010 | £3155 |
| Cancer Targeted Therapies and Immunotherapies Market Forecast | August 2010 | £9885 |
| Neuroprotection | August 2010 | £2925 |
| Pain Therapeutics | August 2010 | £2275 |
| Cell therapy | August 2010 | £1625 |
| Antiviral Therapeutics | August 2010 | £2080 |
| Personalized Medicine | August 2010 | £2600 |
| Market of Paclitaxel Injection in China | July 2010 | £4230 |
| Commercial Insight: Osteoporosis Market players maximize revenue growth before the next challenging phase |
July 2010 | £9885 |
| Migraine Market Forecast | July 2010 | £9885 |
| Pipeline and Commercial Insight - Allergic Rhinitis Immunotherapy growth surpassed by generic erosion |
July 2010 | £9885 |
| Pipeline and Commercial Insight - Insomnia Future of innovative orexin drug class in doubt |
July 2010 | £9885 |
| Antihormonal Therapies Market Forecast | July 2010 | £9885 |
| Multiple Sclerosis Market Forecast | July 2010 | £9885 |
| Commercial Insight Multiple Sclerosis - Next generation therapies signal the start of a new era |
July 2010 | £9885 |
| Pipeline and Commercial Insight - Migraine Challenges ahead for first-in-class developments |
July 2010 | £9885 |
| Innovations and Opportunities in Therapeutic Vaccines Technology platforms, key players, and early pipeline candidates |
July 2010 | £2495 |
